NEXUS SURGICAL AND MEDICARE LI (NEXUSSURGL.BO)
INR 22.99
(1.37%)
INR 22.99
(1.37%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 2.13 Million INR | 24.96% |
| 2022 | 1.7 Million INR | -41.18% |
| 2021 | 2.9 Million INR | 88.44% |
| 2020 | 1.54 Million INR | 102.91% |
| 2019 | -52.95 Million INR | -4652.19% |
| 2018 | -1.11 Million INR | 65.83% |
| 2017 | -3.26 Million INR | -69.38% |
| 2016 | -1.92 Million INR | -492.56% |
| 2015 | 490.41 Thousand INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 899 Thousand INR | 53.94% |
| 2023 Q4 | 584 Thousand INR | 25.32% |
| 2023 Q1 | 269 Thousand INR | 126.74% |
| 2023 FY | 2.13 Million INR | 24.96% |
| 2023 Q2 | 815 Thousand INR | 202.97% |
| 2023 Q3 | 466 Thousand INR | -42.82% |
| 2022 Q2 | -1.41 Million INR | -151.42% |
| 2022 FY | 1.7 Million INR | -41.18% |
| 2022 Q4 | -1 Million INR | -172.85% |
| 2022 Q3 | 1.38 Million INR | 197.94% |
| 2022 Q1 | 2.74 Million INR | 165.13% |
| 2021 Q1 | 1.25 Million INR | 164.3% |
| 2021 Q4 | -4.21 Million INR | -213.02% |
| 2021 FY | 2.9 Million INR | 88.44% |
| 2021 Q3 | 3.72 Million INR | 74.88% |
| 2021 Q2 | 2.13 Million INR | 69.45% |
| 2020 FY | 1.54 Million INR | 102.91% |
| 2020 Q4 | -1.95 Million INR | 0.0% |
| 2019 FY | -52.95 Million INR | -4652.19% |
| 2018 FY | -1.11 Million INR | 65.83% |
| 2017 FY | -3.26 Million INR | -69.38% |
| 2016 FY | -1.92 Million INR | -492.56% |
| 2015 FY | 490.41 Thousand INR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Chandra Bhagat Pharma Limited | 15.3 Million INR | 86.061% |
| Checkpoint Trends Limited | 302.09 Thousand INR | -606.109% |
| Everest Organics Limited | 1.39 Million INR | -53.239% |
| GUJARAT INJECT (KERALA) LTD. | 827.62 Thousand INR | -157.734% |
| NATURO INDIABULL LIMITED | 9.93 Million INR | 78.521% |
| Rajnish Wellness Limited | 10.33 Million INR | 79.355% |
| Rama Vision Limited | 33.85 Million INR | 93.7% |
| Vivo Bio Tech Limited | 25.26 Million INR | 91.556% |